Skip to main content

Table 3 Plasma, organ, and tumor concentrations of MP1 in NSG mice dosed with 15 mg/kg MP1 five times per week orally. Samples collected at necropsy at 30 min or 24 h after dosing of MP1

From: Effects of novel pyrrolomycin MP1 in MYCN amplified chemoresistant neuroblastoma cell lines alone and combined with temsirolimus

Mouse ID

Time of collection

Plasma Conc (ng/mL)

Liver Conc (ng/g)

Lungs Conc (ng/g)

Tumor Conc (ng/g)

Spleen Conc (ng/g)

Fore Brain Conc (ng/g)

Mid Brain Conc (ng/g)

Hind Brain Conc (ng/g)

BE-326

30 min

571.2

4122.2

2154.6

1433.0

AB

52.0

167.3

72.6

BE-329

30 min

244.6

2235.1

1053.2

2156.7

279.7

39.3

30.8

34.5

BE-330

30 min

719.1

2627.7

1719.7

796.6

461.2

56.1

57.8

58.5

BE-327

24 h

6.7

41.8

14.5

3.8

AB

0.5

0.6

0.7

BE-331

24 h

12.2

30.6

11.9

2.3

AB

10.7

13.8

22.7

BE-332

24 h

38.1

46.7

5.5

1.7

1.2

0.2

0.1

0.3